GGrantIndex
← Leaderboards

Kristoffer Valerie

Virginia Commonwealth University

$4,535,545
Attributed
$4,749,014
Total exposure
11
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY200521
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21

Funding mix

By agency

NIH$8,622,191 · 13

By mechanism

P01$4,081,550 · 3
R01$1,989,856 · 2
R21$1,580,227 · 4
S10$722,010 · 2
R03$155,000 · 1
P30$93,548 · 1

Top collaborators

Most similar at Virginia Commonwealth University

Same institution · by research overlap

Others in their field

Top investigators on “Base

Research focus

BaseCellsGliomaRadiationMalignant NeoplasmsProteinsResponseNeoplastic CellAnimalsTumorBrain NeoplasmsSignal TransductionDna RepairGlioblastomaDna DamageInhibitor/AntagonistIn VitroMonitorIonizing RadiationRadiation TherapyIn VivoGenerationsProto-Oncogene Proteins C-AktBrain

Grant awards (33)

Glioblastoma radioimmunotherapy$194,063
R21 · FY2021 · NS
Glioblastoma radioimmunotherapy$232,875
R21 · FY2020 · NS
Porcine brain tumor model for therapeutic experimentation$77,500
R03 · FY2019 · NS · contact PI
Porcine brain tumor model for therapeutic experimentation$77,500
R03 · FY2018 · NS · contact PI
Novel, orally available ATM inhibitor for glioma conformal radiosensitization$165,844
R21 · FY2017 · CA · contact PI
Novel, orally available ATM inhibitor for glioma conformal radiosensitization$199,013
R21 · FY2016 · CA · contact PI
ATM as target for malignant glioma radiosensitization.$333,230
R01 · FY2013 · NS · contact PI
ATM as target for malignant glioma radiosensitization.$320,491
R01 · FY2012 · NS · contact PI
Targeting invasion and DNA DSB repair in glioma with a multi-pronged approach.$195,098
R21 · FY2012 · CA · contact PI
ATM as target for malignant glioma radiosensitization.$19,995
R01 · FY2012 · NS · contact PI
ATM as target for malignant glioma radiosensitization.$320,491
R01 · FY2011 · NS · contact PI
Targeting invasion and DNA DSB repair in glioma with a multi-pronged approach.$162,581
R21 · FY2011 · CA · contact PI
ATM as target for malignant glioma radiosensitization.$37,096
R01 · FY2011 · NS · contact PI
ATM as target for malignant glioma radiosensitization.$323,762
R01 · FY2010 · NS · contact PI
Radiation-induced ATM and ERK signaling in DSB repair$186,250
R21 · FY2010 · ES · contact PI
Virus Vector Shared Resource$38,856
P30 · FY2010 · CA · contact PI
Radiation-induced ATM and ERK signaling in DSB repair$21,003
R21 · FY2010 · ES · contact PI
ATM as target for malignant glioma radiosensitization.$323,135
R01 · FY2009 · NS · contact PI
Radiation-induced ATM and ERK signaling in DSB repair$223,500
R21 · FY2009 · ES · contact PI
Virus Vector Shared Resource$39,525
P30 · FY2009 · CA · contact PI
Virus Vector Shared Resource$15,167
P30 · FY2008 · CA · contact PI
Genetic Modulation of Cellular Radiation Responses$884,463
P01 · FY2007 · CA · contact PI
Genetic Modulation of Cellular Radiation Responses$886,106
P01 · FY2006 · CA · contact PI
GAMMACELL 40 137 CS IRRADIATOR$361,005
S10 · FY2006 · RR · contact PI
Gammacell 40 137 Cs Irradiator$361,005
S10 · FY2006 · RR · contact PI
Genetic Modulation of Cellular Radiation Responses$882,794
P01 · FY2005 · CA
Genetic Modulation of Cellular Radiation Responses$858,809
P01 · FY2004 · CA
CORE--ADENOVIRUS FACILITY$184,121
P01 · FY2001 · CA
GENETIC MANIPULATION OF TUMOR RADIORESISTANCE$184,121
P01 · FY2001 · CA
RADIATION-INDUCED GENE EXPRESSION$260,693
R01 · FY2000 · CA
CORE--ADENOVIRUS FACILITY$100,568
P01 · FY2000 · CA
GENETIC MANIPULATION OF TUMOR RADIORESISTANCE$100,568
P01 · FY2000 · CA
RADIATION-INDUCED GENE EXPRESSION$50,963
R01 · FY2000 · CA